Andy Futreal

2.8k total citations
10 papers, 225 citations indexed

About

Andy Futreal is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Andy Futreal has authored 10 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Andy Futreal's work include Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Andy Futreal is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Andy Futreal collaborates with scholars based in United States, United Kingdom and Canada. Andy Futreal's co-authors include Tim Eisen, Charles Swanton, Carlos Caldas, H. Raza Ali, Julia Stingl, Neal G. Copeland, Walid T. Khaled, Fazal Hadi, Nancy A. Jenkins and Yong Yu and has published in prestigious journals such as Nature Communications, Blood and Clinical Cancer Research.

In The Last Decade

Andy Futreal

9 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Futreal United States 6 134 87 53 41 39 10 225
Steven Hager United States 7 149 1.1× 100 1.1× 48 0.9× 58 1.4× 27 0.7× 19 274
Scott Wood Australia 10 180 1.3× 91 1.0× 71 1.3× 37 0.9× 30 0.8× 21 271
Sonia Ali United States 5 90 0.7× 63 0.7× 51 1.0× 29 0.7× 39 1.0× 11 181
Benjamin Tanenbaum United States 5 130 1.0× 48 0.6× 55 1.0× 48 1.2× 35 0.9× 6 191
J. Infante United States 8 156 1.2× 137 1.6× 38 0.7× 66 1.6× 49 1.3× 17 273
Jason Glover United States 5 115 0.9× 74 0.9× 72 1.4× 79 1.9× 52 1.3× 8 243
Takako Yokomizo‐Nakano Japan 7 137 1.0× 68 0.8× 67 1.3× 16 0.4× 42 1.1× 18 219
Brad Foulk United States 6 94 0.7× 109 1.3× 69 1.3× 67 1.6× 49 1.3× 12 208
Joshua Donaldson United States 7 153 1.1× 97 1.1× 62 1.2× 32 0.8× 26 0.7× 11 263
Gaetanina Golino Switzerland 8 193 1.4× 69 0.8× 43 0.8× 13 0.3× 50 1.3× 16 245

Countries citing papers authored by Andy Futreal

Since Specialization
Citations

This map shows the geographic impact of Andy Futreal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Futreal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Futreal more than expected).

Fields of papers citing papers by Andy Futreal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Futreal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Futreal. The network helps show where Andy Futreal may publish in the future.

Co-authorship network of co-authors of Andy Futreal

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Futreal. A scholar is included among the top collaborators of Andy Futreal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Futreal. Andy Futreal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
White, Michael G., John Paul Shen, Eduardo Vilar, et al.. (2025). Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers. 30(1). 64–76. 6 indexed citations
2.
Merriman, Kelly W., Emily Yu, Andrea Hawkins‐Daarud, et al.. (2025). Data Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and Safety. JCO Clinical Cancer Informatics. 9(9). e2400273–e2400273.
3.
Fan, Huihui, Feng Wang, Andy G.X. Zeng, et al.. (2023). Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. Communications Biology. 6(1). 765–765. 11 indexed citations
4.
Wang, Bofei, Fatima Zahra Jelloul, Guilin Tang, et al.. (2022). Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients. Blood. 140(Supplement 1). 6272–6273. 1 indexed citations
5.
Oran, Betül, Richard E. Champlin, Tomoyuki Tanaka, et al.. (2021). Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia. 36(1). 257–262. 21 indexed citations
6.
Rini, Brian I., E. Jason Abel, Laurence Albigès, et al.. (2020). Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure. Clinical Genitourinary Cancer. 19(2). 167–175. 3 indexed citations
7.
Oran, Betül, Richard E. Champlin, Rui Wang, et al.. (2019). Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients. Blood. 134(Supplement_1). 47–47. 3 indexed citations
8.
Khaled, Walid T., Julia Stingl, Xiongfeng Chen, et al.. (2015). BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nature Communications. 6(1). 5987–5987. 107 indexed citations
9.
Child, Emma S., et al.. (2010). A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(7). 858–864. 17 indexed citations
10.
Swanton, Charles, Andy Futreal, & Tim Eisen. (2006). Her2-Targeted Therapies in Non–Small Cell Lung Cancer. Clinical Cancer Research. 12(14). 4377s–4383s. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026